首页 | 本学科首页   官方微博 | 高级检索  
     


Isolation and characterization of type IV group B Streptococcus capsular polysaccharide.
Authors:M R Wessels, W J Benedí  , H J Jennings, F Michon, J L DiFabio,   D L Kasper
Affiliation:Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Abstract:An antigenically distinct serotype, type IV, has recently been added to the recognized serotypes of group B streptococci (GBS). We isolated and purified the capsular polysaccharide antigen from a prototype type IV GBS strain. The type IV capsular polysaccharide formed a precipitin line with rabbit antiserum to type IV GBS organisms but not with antiserum to organisms of GBS serotype Ia, Ib, II, or III. Enzyme-linked immunosorbent assay inhibition experiments showed no cross-reaction between type IV antiserum and other GBS serotypes. Capsular polysaccharide released from the bacterial cells with mutanolysin and that isolated from the culture supernatant had similar elution profiles on Sepharose CL-6B, with a Kav of 0.30 and an estimated Mr of 200,000. The purified type IV polysaccharide was found to contain galactose, glucose, N-acetylglucosamine, and N-acetylneuraminic acid (sialic acid) as exclusive sugars. The polysaccharide contained 23% (by weight) sialic acid and galactose, glucose, and N-acetylglucosamine in a relative ratio of (1):1.10:0.55. These results are compatible with a repeating structure of six monosaccharide residues containing galactose, glucose, N-acetylglucosamine, and sialic acid in a molar ratio of 2:2:1:1. Unlike type Ia, II, and III GBS polysaccharides, desialylation of the type IV polysaccharide produced an antigen which formed a line of identity with the native type IV antigen in double diffusion in agar against homologous antiserum. This result suggests that sialic acid is not as critical to the immunodeterminant structure of the type IV antigen as it is for other GBS capsular types.
Keywords:
引证文献(本文共被引6次):
[1]、Amanda L. Jones,Rachel H. V. Needham,Anne Clancy,Katherine M. Knoll, Craig E. Rubens.Penicillin-binding proteins in Streptococcus agalactiae: a novel mechanism for evasion of immune clearance[J].Molecular microbiology,2003,47(1):247-256.
[2]、Donald O. Chaffin, Stephen B. Beres, Harry H. Yim, and Craig E. Rubens.The Serotype of Type Ia and III Group B Streptococci Is Determined by the Polymerase Gene within the Polycistronic Capsule Operon[J].Journal of bacteriology,2000,182(16):4466-4477.
[3]、C von Hunolstein, S D\'Ascenzi, B Wagner, J Jelínková, G Alfarone, S Recchia, M Wagner, and G Orefici.Immunochemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (group B streptococci).[J].Infection and immunity,1993,61(4):1272-1280.
[4]、M A Hall, M S Edwards, and C J Baker.Complement and antibody participation in opsonophagocytosis of type IV and V group B streptococci.[J].Infection and immunity,1992,60(12):5030-5035.
[5]、M R Wessels, R F Haft, L M Heggen, and C E Rubens.Identification of a genetic locus essential for capsule sialylation in type III group B streptococci.[J].Infection and immunity,1992,60(2):392-400.
[6]、M R Wessels, L C Paoletti, D L Kasper, J L DiFabio, F Michon, K Holme, and H J Jennings.Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus.[J].The Journal of clinical investigation,1990,86(5):1428-1433.
正在获取相似文献,请稍候...
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号